Although decreasing activity of HIF-1α and/or MMPs by reducing tumor hypoxia could be an effective strategy in cancer treatment, there is currently no effective way of achieving reduction of hypoxia in tumors [5], [9]. The gene discussed is HIF1A; the disease is cancer.